Global Nuclear Medicine Diagnostics Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report ID: ARS1437 | Category: Healthcare | Pages: 107 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3350.00 Multi User-$5700.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine Diagnostics, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine Diagnostics.

The Nuclear Medicine Diagnostics market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nuclear Medicine Diagnostics market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine Diagnostics manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Nuclear Medicine Diagnostics market size in 2022 is XX million US dollars, and it is expected to be 13210.0 million US dollars by 2029, with a compound annual growth rate of 10.60% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Nuclear Medicine Diagnostics market include Cardinal Health (U.S.), General Electric (U.S.), Lantheus (U.S.), Bayer AG (Germany), and Bracco Diagnostic Inc. (Italy). The share of the top 3 players in the Nuclear Medicine Diagnostics market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Nuclear Medicine Diagnostics market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. SPECT Applications accounted for XX% of Nuclear Medicine Diagnostics market in 2022. PET Applications share of XX%.
Hospitals and diagnostic centers accounted for XX% of the Nuclear Medicine Diagnostics market in 2022. Research Institutes accounts for XX%.

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Highlights-Regions

North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
South America
Brazil
Argentina
Colombia
MEA
Saudi Arabia
Egypt
Nigeria

Player list
Cardinal Health (U.S.)
General Electric (U.S.)
Lantheus (U.S.)
Bayer AG (Germany)
Bracco Diagnostic Inc. (Italy)
NorthStar Medical Radioisotopes, LLC (U.S.)
Eckert & Ziegler. (Germany)
Jubilant DraxImage, Inc. (Canada)
PharmaLogic Holdings Corp. (U.S.)
Institute of Isotopes Co., Ltd (Hungary)
SHINE Medical Technologies, LLC (U.S.)
Global Medical Solutions LLC (China)

Types list
SPECT Applications
PET Applications

Application list
Hospitals and diagnostic centers
Research Institutes

Table of Content

1 Nuclear Medicine Diagnostics Market Overview
1.1 Nuclear Medicine Diagnostics Product Overview
1.1.1 Nuclear Medicine Diagnostics Product Scope
1.1.2 Nuclear Medicine Diagnostics Market Status and Outlook
1.2 Global Nuclear Medicine Diagnostics Market Size Overview by Region 2018 VS 2022VS 2029
1.3 Global Nuclear Medicine Diagnostics Market Size by Region (2018-2029)
1.4 Global Nuclear Medicine Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Nuclear Medicine Diagnostics Market Size Forecast by Region (2023-2029)
1.6 Key Regions, Nuclear Medicine Diagnostics Market Size (2018-2029)
1.6.1 North America Nuclear Medicine Diagnostics Market Size (2018-2029)
1.6.2 Europe Nuclear Medicine Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Nuclear Medicine Diagnostics Market Size (2018-2029)
1.6.4 Latin America Nuclear Medicine Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Nuclear Medicine Diagnostics Market Size (2018-2029)
2 Nuclear Medicine Diagnostics Market Overview by Type
2.3 Global Nuclear Medicine Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.4 Global Nuclear Medicine Diagnostics Historic Market Size by Type (2018-2023)
2.5 Global Nuclear Medicine Diagnostics Forecasted Market Size by Type (2023-2029)
2.6 Key Regions Market Size Segment by Type (2018-2029)
2.6.1 North America Nuclear Medicine Diagnostics Market Size Breakdown by Type (2018-2029)
2.6.2 Europe Nuclear Medicine Diagnostics Market Size Breakdown by Type
2.6.3 Asia-Pacific Nuclear Medicine Diagnostics Market Size Breakdown by Type
2.6.4 Latin America Nuclear Medicine Diagnostics Market Size Breakdown by Type
2.6.5 Middle East and Africa Nuclear Medicine Diagnostics Market Size Breakdown by Type
3 Nuclear Medicine Diagnostics Market Overview by Application
3.3 Global Nuclear Medicine Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.4 Global Nuclear Medicine Diagnostics Historic Market Size by Application (2018-2023)
3.5 Global Nuclear Medicine Diagnostics Forecasted Market Size by Application (2023-2029)
3.6 Key Regions Market Size Segment by Application (2018-2029)
3.6.1 North America Nuclear Medicine Diagnostics Market Size Breakdown by Application (2018-2029)
3.6.2 Europe Nuclear Medicine Diagnostics Market Size Breakdown by Application
3.6.3 Asia-Pacific Nuclear Medicine Diagnostics Market Size Breakdown by Application
3.6.4 Latin America Nuclear Medicine Diagnostics Market Size Breakdown by Application
3.6.5 Middle East and Africa Nuclear Medicine Diagnostics Market Size Breakdown by Application
4 Nuclear Medicine Diagnostics Competition Analysis by Players
4.1 Global Nuclear Medicine Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Medicine Diagnostics as of 2022)
4.3 Date of Key Players Enter into Nuclear Medicine Diagnostics Market
4.4 Global Top Players Nuclear Medicine Diagnostics Headquarters and Area Served
4.5 Key Players Nuclear Medicine Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Nuclear Medicine Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 North America Nuclear Medicine Diagnostics Market Segment by Country
5.1 North America Nuclear Medicine Diagnostics Market Size by Country (2018-2029)
5.2 United States
5.3 Canada
6 Europe Nuclear Medicine Diagnostics Market Segment by Country
6.1 Europe Nuclear Medicine Diagnostics Market Size by Country (2018-2029)
6.2 Germany
6.3 France
6.4 U.K.
6.5 Italy
6.6 Russia
6.7 Nordic
6.8 Rest of Europe
7 Asia-Pacific Nuclear Medicine Diagnostics Market Segment by Country
7.1 Asia-Pacific Nuclear Medicine Diagnostics Market Size by Region (2018-2029)
7.2 China
7.3 Japan
7.4 South Korea
7.5 Southeast Asia
7.6 India
7.7 Australia
7.8 Rest of Asia-Pacific
8 Latin America Nuclear Medicine Diagnostics Market Segment by Country
8.1 Latin America Nuclear Medicine Diagnostics Market Size by Country (2018-2029)
8.2 Mexico
8.3 Brazil
8.4 Rest of Latin America
9 Middle East and Africa Nuclear Medicine Diagnostics Market Segment by Country
9.1 Middle East & Africa Nuclear Medicine Diagnostics Market Size by Country (2018-2029)
9.2 Turkey
9.3 Saudi Arabia
9.4 UAE
9.5 Rest of Middle East & Africa
10 Manufacturers Profiles
10.1  Cardinal Health (U.S.)
10.1.1 Cardinal Health (U.S.) Information
10.1.2 Business Overview
10.1.3 Cardinal Health (U.S.) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.1.4 Nuclear Medicine Diagnostics Products Offered
10.1.5 Cardinal Health (U.S.) Recent Development
10.2  General Electric (U.S.)
10.2.1 General Electric (U.S.) Information
10.2.2 Business Overview
10.2.3 General Electric (U.S.) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.2.4 Nuclear Medicine Diagnostics Products Offered
10.2.5 General Electric (U.S.) Recent Development
10.3  Lantheus (U.S.)
10.3.1 Lantheus (U.S.) Information
10.3.2 Business Overview
10.3.3 Lantheus (U.S.) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.3.4 Nuclear Medicine Diagnostics Products Offered
10.3.5 Lantheus (U.S.) Recent Development
10.4  Bayer AG (Germany)
10.4.1 Bayer AG (Germany) Information
10.4.2 Business Overview
10.4.3 Bayer AG (Germany) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.4.4 Nuclear Medicine Diagnostics Products Offered
10.4.5 Bayer AG (Germany) Recent Development
10.5  Bracco Diagnostic Inc. (Italy)
10.5.1 Bracco Diagnostic Inc. (Italy) Information
10.5.2 Business Overview
10.5.3 Bracco Diagnostic Inc. (Italy) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.5.4 Nuclear Medicine Diagnostics Products Offered
10.5.5 Bracco Diagnostic Inc. (Italy) Recent Development
10.6  NorthStar Medical Radioisotopes, LLC (U.S.)
10.6.1 NorthStar Medical Radioisotopes, LLC (U.S.) Information
10.6.2 Business Overview
10.6.3 NorthStar Medical Radioisotopes, LLC (U.S.) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.6.4 Nuclear Medicine Diagnostics Products Offered
10.6.5 NorthStar Medical Radioisotopes, LLC (U.S.) Recent Development
10.7  Eckert & Ziegler. (Germany)
10.7.1 Eckert & Ziegler. (Germany) Information
10.7.2 Business Overview
10.7.3 Eckert & Ziegler. (Germany) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.7.4 Nuclear Medicine Diagnostics Products Offered
10.7.5 Eckert & Ziegler. (Germany) Recent Development
10.8  Jubilant DraxImage, Inc. (Canada)
10.8.1 Jubilant DraxImage, Inc. (Canada) Information
10.8.2 Business Overview
10.8.3 Jubilant DraxImage, Inc. (Canada) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.8.4 Nuclear Medicine Diagnostics Products Offered
10.8.5 Jubilant DraxImage, Inc. (Canada) Recent Development
10.9  PharmaLogic Holdings Corp. (U.S.)
10.9.1 PharmaLogic Holdings Corp. (U.S.) Information
10.9.2 Business Overview
10.9.3 PharmaLogic Holdings Corp. (U.S.) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.9.4 Nuclear Medicine Diagnostics Products Offered
10.9.5 PharmaLogic Holdings Corp. (U.S.) Recent Development
10.10  Institute of Isotopes Co., Ltd (Hungary)
10.10.1 Institute of Isotopes Co., Ltd (Hungary) Information
10.10.2 Business Overview
10.10.3 Institute of Isotopes Co., Ltd (Hungary) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.10.4 Nuclear Medicine Diagnostics Products Offered
10.10.5 Institute of Isotopes Co., Ltd (Hungary) Recent Development
10.11  SHINE Medical Technologies, LLC (U.S.)
10.11.1 SHINE Medical Technologies, LLC (U.S.) Information
10.11.2 Business Overview
10.11.3 SHINE Medical Technologies, LLC (U.S.) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.11.4 Nuclear Medicine Diagnostics Products Offered
10.11.5 SHINE Medical Technologies, LLC (U.S.) Recent Development
10.12  Global Medical Solutions LLC (China)
10.12.1 Global Medical Solutions LLC (China) Information
10.12.2 Business Overview
10.12.3 Global Medical Solutions LLC (China) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.12.4 Nuclear Medicine Diagnostics Products Offered
10.12.5 Global Medical Solutions LLC (China) Recent Development
11 Nuclear Medicine Diagnostics Market Dynamics
11.1 Nuclear Medicine Diagnostics Industry Trends
11.2 Nuclear Medicine Diagnostics Growth Drivers
11.3 Nuclear Medicine Diagnostics Market Challenges
11.4 Nuclear Medicine Diagnostics Market Restraints
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 A Methodology
13.1.1 Research Process
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 B Data Source
13.2.1 Legal Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Nuclear Medicine Diagnostics Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?